期刊文献+

国内外药品说明书和标签管理中有关警示语的比较研究 被引量:18

Comparison of Related Content of Warnings in Drug Labels and Package Inserts at Home and Abroad
原文传递
导出
摘要 目的:为进一步改进和完善我国药品说明书和标签中警示语的管理提供参考。方法:通过查阅国内外有关药品说明书和标签管理的法规和文献,比较分析其中关于警示语的内容和管理规定。结果与结论:与国外相比,我国药品说明书和标签在警示语内容上力求最大程度地确保用药安全和有效,尽可能地提供准确、充分、全面、清晰的药品信息,但在增强清晰性和易读性方面尚需提高;在管理与法规方面没有明确具体的标准,尚需细化和完善。建议健全警示语的相关管理规范、强化相关法律责任、改进表达形式,用更形象易懂的文字或图形提醒用药人群。 OBJECTIVE: To provide reference for further improvement and perfection of the management of warnings in drug labels and package inserts in China. METHODS: By reviewing the related regulations of drug package inserts and labels and some literatures at home and abroad, the related content and regulations of warnings were analyzed comparatively. RESULTS & CONCLUSIONS: Compared with foreign countries, the content of warnings in drug labels and package inserts strive to guarantee the safety and effectiveness of drug use furthest and provide accurate, enough, complete and clear drug information as much as possible in China; but there still is a long way to go to improve both the clarity and legibility of format related to the drug warnings. There is no definite management standard and laws, which should be refined and improved. It is suggested that we could further standardize the management of the warnings, strengthen the legal responsibility and improve expression so as to present the warnings more popular and easy to understand in image mode.
作者 洪兰 朱俊怡
出处 《中国药房》 CAS CSCD 2014年第33期3161-3164,共4页 China Pharmacy
关键词 药品说明书 标签 警示语 国内外 Drug package inserts Labels Warnings At home and abroad
  • 相关文献

参考文献3

二级参考文献12

  • 1百时美施贵宝公司修改羟基脲说明书[J].中国药物警戒,2006,3(4):249-249. 被引量:1
  • 2国家食品药品监督管理局.药品说明书和标签管理规定[EB/OL].2006-03-15[2009-01-12].http://www.sfda.gov.cn/WS01/CL0053/24522.html.
  • 3国家食品药品监督管理局.法规文件[EB/OL].http://www.sfda.gov.cn/WS01/CL0006/.2009-10-26.
  • 4FDA. Guidance drug safety information-FDA's communication to the public[EB/OL], http.//www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM072281.pdf.2007.2009-10.
  • 5The Food and Drug Administration. Milestones in U.S. Food and Drug Law, History[EB/OL] . http://www. fda. gov/cder/whatsnew. htm. 2005. 2006 - 12 - 26.
  • 6The Food and Drug Administration. Center for drug evaluation and research. NDAs: Foreign Language Labeling [ EB/OL ] . http ://www. fda. gov/cder/mapp. pdf. 2004. 2006- 12 - 26.
  • 7The Food and Drug Administration. The History of Drug Regulation in the United States [EB/OL] .http:// www. fda. gov/cder/whatsnew. htm. 2006. 2007 - 1 - 22.
  • 8Department of health and human services U.S Food and drug administration.Section 201.57.Specific requirements on content and format of labeling for human prescription drug and biological products.Part 201 labeling Title21 code of Federal Regulations USA[EB/OL].http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=201.57.2006,2007-2-9.
  • 9Department of health and human services U.S Food and drug administration.Section 201.66:Format and content requirements for over-the-counter(OTC)drug product labeling.Part 201 labeling Title 21 Code of Federal Regulations USA[EB/OL].http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSSearch.cfm?fr=201.66.2006.2007-2-18.
  • 10the Food and Drug Administration.FD & C Act Chapter Ⅶ,Subchapter F[EB/OL].http://www.fda.gov/opacom/laws/fdcact/fdctoc.html.2003,2007-3-4.

共引文献46

同被引文献161

引证文献18

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部